BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27153516)

  • 1. Intertriginous eruption induced by terbinafine: a review of baboon syndrome.
    Janjua SA; Pastar Z; Iftikhar N; Ammad S
    Int J Dermatol; 2017 Jan; 56(1):100-103. PubMed ID: 27153516
    [No Abstract]   [Full Text] [Related]  

  • 2. Terbinafine-induced acute generalized exanthematous pustulosis confirmed by a positive patch-test result.
    Kempinaire A; De Raeve L; Merckx M; De Coninck A; Bauwens M; Roseeuw D
    J Am Acad Dermatol; 1997 Oct; 37(4):653-5. PubMed ID: 9344212
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute generalized exanthematous pustulosis induced by terbinafine.
    Dupin N; Gorin I; Djien V; Helal H; Zylberberg L; Leibowitch M; Escande JP
    Arch Dermatol; 1996 Oct; 132(10):1253-4. PubMed ID: 8859047
    [No Abstract]   [Full Text] [Related]  

  • 4. Symmetrical drug-related intertriginous and flexural erythema (Baboon syndrome) induced by simultaneous exposure to oral and topical terbinafine.
    Bhari N; Sahni K; Dev T; Sharma VK
    Int J Dermatol; 2017 Aug; 56(8):e168-e170. PubMed ID: 28244137
    [No Abstract]   [Full Text] [Related]  

  • 5. Baboon syndrome and toxic erythema of chemotherapy: Fold (intertriginous) dermatoses.
    Wolf R; Tüzün Y
    Clin Dermatol; 2015; 33(4):462-5. PubMed ID: 26051062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) associated with pristinamycin, secnidazole, and nefopam, with a review of the literature.
    Nespoulous L; Matei I; Charissoux A; Bédane C; Assikar S
    Contact Dermatitis; 2018 Dec; 79(6):378-380. PubMed ID: 30062790
    [No Abstract]   [Full Text] [Related]  

  • 7. Coix lacryma-jobi associated symmetrical drug-related intertriginous and flexural exanthema.
    Choi MJ; Oh SH; Cho SB
    Int J Dermatol; 2014 Apr; 53(4):e301-3. PubMed ID: 24261789
    [No Abstract]   [Full Text] [Related]  

  • 8. Terbinafine-induced lichenoid drug eruption.
    Zheng Y; Zhang J; Chen H; Lai W; Maibach HI
    Cutan Ocul Toxicol; 2017 Mar; 36(1):101-103. PubMed ID: 26938740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symmetrical drug-related intertriginous and flexural exanthema like eruption associated with COVID-19 vaccination.
    Lim PN; Wylie G
    Clin Exp Dermatol; 2022 Jan; 47(1):175-176. PubMed ID: 34399001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic approach to systemic contact dermatitis and symmetric drug-related intertriginous and flexural exanthema (SDRIFE): a closer look at these conditions and an approach to intertriginous eruptions.
    Winnicki M; Shear NH
    Am J Clin Dermatol; 2011 Jun; 12(3):171-80. PubMed ID: 21469762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute generalized exanthematous pustulosis associated with oral terbinafine.
    Hall AP; Tate B
    Australas J Dermatol; 2000 Feb; 41(1):42-5. PubMed ID: 10715900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronic acid-associated symmetrical drug-related intertriginous and flexural exanthema (SDRIFE): report of baboon syndrome in a woman with recurrent metastatic breast cancer after receiving zoledronic acid.
    Cohen PR
    Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pustular psoriasis induced by terbinafine : differential diagnosis from acute generalized exanthematous pustulosis.
    Tokuyama Y; Senoh A; Setsu N; Iwatsuki K
    Eur J Dermatol; 2008; 18(6):725-6. PubMed ID: 19049946
    [No Abstract]   [Full Text] [Related]  

  • 14. Pustulobullous variant of SDRIFE (symmetrical drug-related intertriginous and flexural exanthema).
    Magnolo N; Metze D; Ständer S
    J Dtsch Dermatol Ges; 2017 Jun; 15(6):657-659. PubMed ID: 28514083
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe erythema anulare centrifugum-like psoriatic drug eruption induced by terbinafine.
    Wach F; Stolz W; Hein R; Landthaler M
    Arch Dermatol; 1995 Aug; 131(8):960-1. PubMed ID: 7632075
    [No Abstract]   [Full Text] [Related]  

  • 16. Amoxycillin-induced flexural exanthem.
    Wakelin SH; Sidhu S; Orton DI; Chia Y; Shaw S
    Clin Exp Dermatol; 1999 Mar; 24(2):71-3. PubMed ID: 10233656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Generalized pruritic eruption during terbinafine treatment].
    Amouri M; El Euch D; El Ouni B; Daoued O; Ouselati MH; Ferjani M; Dhahri AB
    Presse Med; 2008 Dec; 37(12):1836-40. PubMed ID: 18656325
    [No Abstract]   [Full Text] [Related]  

  • 18. Baboon syndrome resulting from systemic drugs: is there strife between SDRIFE and allergic contact dermatitis syndrome?
    Häusermann P; Harr T; Bircher AJ
    Contact Dermatitis; 2004; 51(5-6):297-310. PubMed ID: 15606657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docetaxel-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) confirmed by skin testing.
    Hampel A; Kinaciyan T
    Contact Dermatitis; 2024 May; 90(5):525-527. PubMed ID: 38263696
    [No Abstract]   [Full Text] [Related]  

  • 20. Symmetrical drug-related intertriginous and flexural exanthema induced by metronidazole suppository.
    Zhang H; Xie Z
    Contact Dermatitis; 2021 Jun; 84(6):486-488. PubMed ID: 33421140
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.